Completed NA INTERVENTIONAL 6-arm NCT01656057

The Impact of Gall Bladder Emptying and Bile Acids on the Human GLP-1-secretion

Sponsor: Filip Krag Knop

Conditions To Assess the Impact of Bile Acids on Human Glukagon-like-peptide-1 Secretion

Interventions Acetaminophen Cholecystokinin-8 Colesevelam Metformin Saline

Updated 5 times since 2017 Last updated: Jul 10, 2015 Started: Jul 31, 2012 Primary completion: Oct 31, 2013 Completion: Apr 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates To Assess the Impact of Bile Acids on Human Glukagon-like-peptide-1 Secretion and is currently completed. Filip Krag Knop leads this study, which shows 5 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jul 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Filip Krag Knop
University of Copenhagen

Data source: University Hospital, Gentofte, Copenhagen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Copenhagen, Hellerup, Denmark